Dinitrochlorobenzene immunotherapy for verrucae resistant to standard treatment modalities
- 1 January 1982
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 6 (1) , 40-45
- https://doi.org/10.1016/s0190-9622(82)80199-0
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Suppression of Allergic Contact Dermatitis by α-L-fucoseJournal of Investigative Dermatology, 1980
- 1-Chloro-2,4-dinitrobenzene depletes glutathione in rat skin and is mutagenic in Salmonella typhimuriumMutation Research/Genetic Toxicology, 1980
- Immunology of human wartsJournal of the American Academy of Dermatology, 1979
- TOPICAL DNCB THERAPY FOR RESISTANT WARTSAustralasian Journal of Dermatology, 1978
- Immunotherapy of verrucae vulgares with dinitrochlorobenzeneBritish Journal of Dermatology, 1978
- DNCB, chemical laboratory workers, and chloramphenicol.BMJ, 1976
- The role of langerhans cells in allergic contact hypersensitivity. A review of findings in man and guinea pigsJournal of Investigative Dermatology, 1976
- Suppression of Contact Sensitization in Man by Prior Feeding of AntigenJournal of Investigative Dermatology, 1973
- Verrucae vulgaris rejection. A preliminary study of contact dermatitis and cellular immunity responseArchives of Dermatology, 1973
- A Method for Dinitrochlorobenzene Contact SensitizationNew England Journal of Medicine, 1972